Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
CXCR4 Blocking Peptide (AC1262)
Cat.#: ACPP-1262
Specifications
Despition CXCR4 Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1328 MRAP2 Blocking Peptide (AC1328) 250 µg inquiry ACPP-1719 Human FDFT1 Protein (AC1719) 2 µg inquiry ACPP-1581 Rat FGF 9 Protein (AC1581) 2 µg inquiry ACPP-1042 Recombinant Human BACE1 Protein (6×His Tag) (AC1042) 50 µg inquiry ACPP-1702 Human PCSK1N Protein (AC1702) 2 µg inquiry ACPP-1354 PAX2 Blocking Peptide (AC1354) 250 µg inquiry ACPP-1294 DCC Blocking Peptide (AC1294) 250 µg inquiry ACPP-1462 Human CD34 Protein (AC1462) 5 µg inquiry ACPP-1230 MC3 Receptor Blocking Peptide (AC1230) 250 µg inquiry ACPP-1234 SOX10 Blocking Peptide (AC1234) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket